14 Oct 2013 Date | | - Cons. EPS | - EPS |
29 Jul 2013 Date | | - Cons. EPS | - EPS |
11 Apr 2013 Date | | - Cons. EPS | - EPS |
14 Oct 2013 Date | | - Cons. EPS | - EPS |
29 Jul 2013 Date | | - Cons. EPS | - EPS |
11 Apr 2013 Date | | - Cons. EPS | - EPS |
Shell Companies Industry | Financial Services Sector | Mr. Jason Price CEO | OTC PINK Exchange | US0024322010 ISIN |
US Country | 5 Employees | - Last Dividend | 5 Jun 2008 Last Split | - IPO Date |
AVVAA World Health Care Products, Inc. specializes in natural and therapeutic skincare solutions offered globally. As a biotechnology entity, it dedicates its efforts to the development, manufacture, and marketing of the Neuroskin line of products. These offerings cater primarily to skin abnormalities and aim to enhance the clarity and texture of healthy skin via mass-market channels, including food and drug outlets. With its foundation laid in 1998 and headquartered in Richmond, Virginia, AVVAA has expanded its footprint by securing distribution rights for patented European skincare innovations designed for skin disease symptoms. The acquisition by Gold Quest Capital, Inc. on June 23, 2021, marked a new chapter, positioning AVVAA as its subsidiary, thereby broadening its operational and strategic capabilities in the biotechnology and healthcare products domain.
AVVAA World Health Care Products, Inc. offers a diverse portfolio of skin and animal care products, focusing on natural ingredients and therapeutic benefits. These include: